Ming-Yang Lai, MD, PhD
National Taiwan University Hospital
2
1
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mostafa Gabr, MD
Cairo University
Shared therapeutic areas:
Wahid Doss, MD
Cairo University
Shared therapeutic areas:
Mohamed A Afify, MD
Cairo University
Shared therapeutic areas:
Gamal Sheha, MD
Cairo University
Shared therapeutic areas:
Noaman Al-Garem, MD
Cairo University
Shared therapeutic areas:
Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Gamal Esmat, MD
Cairo University
Shared therapeutic areas:
Tawheed Mwafy, MD
Cairo University
Shared therapeutic areas:
Osama E Salem, MD
Cairo University
Shared therapeutic areas:
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-infected Patients
Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
All 2 trials loaded